MariMed CCO exercises 54K RSUs, pays taxes in stock
MariMed Inc. Chief Commercial Officer Ryan Crandall reported compensation-related equity activity.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
MariMed Inc. Chief Commercial Officer Ryan Crandall reported compensation-related equity activity. He exercised 54,000 Restricted Stock Units (RSUs), which converted into an equal number of common shares. In connection with this vesting, 18,711 common shares were withheld by MariMed to cover tax obligations, rather than sold on the open market. Following these transactions, Crandall directly holds 939,429 shares of MariMed common stock, reflecting a routine RSU vesting and associated tax-withholding disposition.
Insider Trade Summary
54,000 shares exercised/converted
Exercise
3 txns
Insider
Crandall Ryan
Role
Chief Commercial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units (RSU) | 54,000 | $0.00 | $0.00 |
| Exercise | Common stock | 54,000 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common stock | 18,711 | $0.0755 | $1K |
Holdings After Transaction:
Restricted Stock Units (RSU) — 0 contracts (Direct);
Common stock — 939,429 shares (Direct)
Footnotes (3)
- F1. RSUs convert to shares of common stock on a one-for-one basis.
- F2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
- F3. The RSUs were granted on June 8, 2023; there are no outstanding RSUs remaining under this grant, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
Key Figures
RSUs exercised: 54,000 units
Shares withheld for taxes: 18,711 shares
Tax value per share: $0.0755 per share
+2 more
5 metrics
RSUs exercised
54,000 units
RSUs converted one-for-one into common stock on June 8, 2026
Shares withheld for taxes
18,711 shares
Common stock withheld to satisfy RSU-related tax obligations
Tax value per share
$0.0755 per share
Reported value used for tax-withholding disposition
Post-transaction holdings (step 1)
939,429 shares
Direct common stock holdings after tax-withholding transaction
Post-transaction holdings (final)
958,140 shares
Direct common stock holdings after RSU exercise
Key Terms
Restricted Stock Units (RSU), tax withholding obligations, derivative security, one-for-one basis, +1 more
5 terms
Restricted Stock Units (RSU) financial
"security_title: "Restricted Stock Units (RSU)""
tax withholding obligations financial
"shares of common stock withheld by the Issuer to satisfy tax withholding obligations"
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
one-for-one basis financial
"RSUs convert to shares of common stock on a one-for-one basis"
award agreement financial
"in accordance with the terms of an award agreement between the Issuer and the Reporting Person"
An award agreement is a legal contract that spells out the terms of a pay or equity grant—such as stock options, restricted shares, or cash bonuses—given to an employee, director or consultant. It describes what is being granted, any conditions for keeping it (for example, earning it over time or meeting performance targets), and what happens if the person leaves or breaks rules. Investors care because these agreements affect company costs, potential share dilution and how executives are motivated and rewarded.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MariMed (MRMD) report for Ryan Crandall?
MariMed reported that Chief Commercial Officer Ryan Crandall exercised 54,000 Restricted Stock Units, which converted into 54,000 common shares. A portion of these shares was withheld by the company to satisfy tax obligations related to the RSU vesting event.
How many RSUs did MariMed’s CCO convert to common stock?
Ryan Crandall converted 54,000 Restricted Stock Units into 54,000 shares of MariMed common stock. The RSUs convert on a one-for-one basis, consistent with the award agreement terms disclosed, completing this specific RSU grant from June 8, 2023.
Were the MariMed (MRMD) insider transactions open-market sales or tax withholding?
The filing shows a tax-withholding disposition, not an open-market sale. MariMed withheld 18,711 common shares to cover tax obligations triggered by the vesting of Ryan Crandall’s RSUs, consistent with standard equity compensation practices.
What does the Form 4 say about Ryan Crandall’s remaining RSUs at MariMed?
The Form 4 notes there are no RSUs remaining under this specific June 8, 2023 grant. All 54,000 RSUs were converted into common shares, fully exhausting that award in accordance with the related equity award agreement between MariMed and Crandall.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates